Skip to main content
TipRanks
Go Ultimate75% OFF

Puma Biotechnology (PBYI) Balance Sheet

679 Followers

Puma Biotechnology Balance Sheet

Puma Biotechnology's total assets for Q3 2026 were $202.77M, an increase of 5.21% from the previous quarter. PBYI total liabilities were $56.15M for the fiscal quarter, a 3.62% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 216.30M$ 213.33M$ 230.53M$ 222.06M$ 226.59M
$ 85.96M$ 121.21M$ 177.09M$ 200.45M$ 229.03M
$ 130.34M$ 92.13M$ 53.44M$ 21.61M$ -2.45M

Currency in USD

Puma Biotechnology Liabilities to Assets

0100M200M300M30 %60 %90 %120 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets